Hugel Inc
Hugel, Inc. develops and manufactures biopharmaceuticals in South Korea and internationally. The company offers Botulinum Toxin, a white injectable dry powder in a transparent glass vial for use in the treatment of positive essential eyelid convulsion in adults over 18 years of age; improvement of severe lasso wrinkles associated with corrugator muscles and/or procerus muscle activities in adults… Read more
Hugel Inc (145020) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.020x
Based on the latest financial reports, Hugel Inc (145020) has a cash flow conversion efficiency ratio of 0.020x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩18.38 Billion) by net assets (₩934.27 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Hugel Inc - Cash Flow Conversion Efficiency Trend (2014–2024)
This chart illustrates how Hugel Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Hugel Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Hugel Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Vapores
SN:VAPORES
|
-0.073x |
|
Jiangnan Mould & Plastic Technology Co Ltd
SHE:000700
|
0.090x |
|
BELL FOOD GRP AG NA.SF0,5
F:BWGA
|
N/A |
|
Telling Telecommunication Holding Co Ltd
SHE:000829
|
-0.234x |
|
Amara Raja Batteries Limited
NSE:ARE&M
|
0.068x |
|
Yantai Tayho Advanced Materials Co Ltd
SHE:002254
|
0.045x |
|
Shanghai Fortune Techgroup Co Ltd
SHE:300493
|
0.105x |
|
Lindab International AB
ST:LIAB
|
0.071x |
Annual Cash Flow Conversion Efficiency for Hugel Inc (2014–2024)
The table below shows the annual cash flow conversion efficiency of Hugel Inc from 2014 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩840.81 Billion | ₩149.05 Billion | 0.177x | +17.42% |
| 2023-12-31 | ₩779.68 Billion | ₩117.71 Billion | 0.151x | +48.32% |
| 2022-12-31 | ₩792.11 Billion | ₩80.63 Billion | 0.102x | -7.96% |
| 2021-12-31 | ₩777.09 Billion | ₩85.94 Billion | 0.111x | +11.14% |
| 2020-12-31 | ₩746.67 Billion | ₩74.30 Billion | 0.100x | -9.59% |
| 2019-12-31 | ₩699.50 Billion | ₩76.99 Billion | 0.110x | +21.74% |
| 2018-12-31 | ₩727.72 Billion | ₩65.80 Billion | 0.090x | -2.01% |
| 2017-12-31 | ₩695.71 Billion | ₩64.19 Billion | 0.092x | -48.33% |
| 2016-12-31 | ₩252.80 Billion | ₩45.14 Billion | 0.179x | +87.79% |
| 2015-12-31 | ₩207.85 Billion | ₩19.76 Billion | 0.095x | -52.12% |
| 2014-12-31 | ₩53.21 Billion | ₩10.57 Billion | 0.199x | -- |